Anxiofit

Anxiofit is a Hungarian biotechnology company founded in 2007 by neuroscientists Prof. Tamas Freund and Prof. Jozsef Haller. The company specializes in the development of scientifically-backed dietary supplements and pharmaceutical ingredients derived from unique strains of Echinacea angustifolia. Its flagship product, EP107™, is a patented root extract standardized for a specific alkamide profile that targets the endocannabinoid system to alleviate mild anxiety and stress. Clinical research, including Phase 2 trials for generalized anxiety disorder, has demonstrated that EP107™ provides rapid anxiolytic effects without the sedative side effects or addiction risks associated with traditional medications. Anxiofit's products are marketed globally under various brand names, including AnxioCalm in North America and Anxiofit-1 in Europe. The company operates through strategic partnerships for manufacturing and distribution, maintaining a strong focus on neuroscience-driven product development.